APRIL Induces Cisplatin Resistance in Gastric Cancer Cells via Activation of the NF-κB Pathway | Zendy

Xiaofei Zhi | Zendy; Jinqiu Tao | Zendy; Guoliang Xiang | Zendy; Hongyong Cao | Zendy; Zijun Liu | Zendy; Kun-Xing Yang | Zendy; Chengyu Lv | Zendy; Shao-Zhong Ni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

APRIL Induces Cisplatin Resistance in Gastric Cancer Cells via Activation of the NF-κB Pathway

Author(s) -

Xiaofei Zhi,

Jinqiu Tao,

Guoliang Xiang,

Hongyong Cao,

Zijun Liu,

Kun-Xing Yang,

Chengyu Lv,

Shao-Zhong Ni

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000369720

Subject(s) - cisplatin , cancer research , cancer , immunohistochemistry , apoptosis , tumor necrosis factor alpha , cancer cell , medicine , in vivo , biology , pathology , immunology , chemotherapy , biochemistry , microbiology and biotechnology

A proliferation-inducing ligand (APRIL) is a tumor-necrosis factor (TNF) family member and is a novel cytokine crucial in sustaining lymphocytic leukemia B cell survival and proliferation. However, its role in gastric cancer (GC) remains unclear. In this study, we investigated the expression pattern and prognostic role of APRIL in GC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research